✦ LIBER ✦

Immunosuppressive therapy with cyclophosphamide pulse doses in Wegener’s granulomatosis

✍ Scribed by D Mitrovic; M Popovic; D Stefanovic; B Glisic; M Dimitrijevic

Book ID: 117230982
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 141 KB
Volume: 33
Category: Article
ISSN: 0041-1345
DOI: 10.1016/s0041-1345(01)02028-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pulse cyclophosphamide therapy for wegen

Pulse cyclophosphamide therapy for wegener's granulomatosis

✍ John S. Cowdery 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 275 KB

IMMUNOSUPPRESSIVE THERAPY IN WEGENER'S G

IMMUNOSUPPRESSIVE THERAPY IN WEGENER'S GRANULOMATOSIS

✍ Teisberg, Per ;Enger, Erik 📂 Article 📅 2009 🏛 Wiley (Blackwell Publishing) ⚖ 225 KB

Pulse cyclophosphamide therapy in Wegene

Pulse cyclophosphamide therapy in Wegener's granulomatosis: a pilot study

✍ A. A. DROSOS; L. I. SAKKAS; A. GOUSSIA; K. C. SIAMOPOULOS; H. M. MOUTSOPOULOS 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 246 KB

Treatment of Wegener's granulomatosis wi

Treatment of Wegener's granulomatosis with intermittent high-dose intravenous cyclophosphamide

✍ Gary S. Hoffman; Randi Y. Leavitt; Thomas A. Fleisher; James R. Minor; Anthony S 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 994 KB

Renal cell carcinoma associated immunosu

Renal cell carcinoma associated immunosuppressive therapy: a case report with Wegener’s granulomatosis

✍ Serpil Muge Deger; Ruya Mutluay; Fatma Ayerden Ebinc; Turgay Arinsoy; Sukru Sind 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 144 KB

Ovarian reserve diminished by oral cyclo

Ovarian reserve diminished by oral cyclophosphamide therapy for granulomatosis with polyangiitis (Wegener's)

✍ Megan E. B. Clowse; Susannah C. Copland; Tsung-Cheng Hsieh; Shein-Chung Chow; Ga 📂 Article 📅 2011 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 108 KB 👁 2 views

## Abstract ## Objective Standard treatment for severe granulomatosis with polyangiitis (Wegener's) (GPA) is daily oral cyclophosphamide (CYC), a cytotoxic agent associated with ovarian failure. In this study, we assessed the rate of diminished ovarian reserve in women with GPA who received CYC ve